CG Oncology Inc. (NASDAQ:CGON) is one of the best hot stocks to invest in. On October 8, Guggenheim analyst Brad Canino ...
Petros Grivas, MD, PhD, discusses the overall survival and quality-of-life findings from the JAVELIN Bladder 100 trial of ...
Discover the most anticipated abstracts on renal cell carcinoma and bladder cancer at the 2025 ESMO Congress in Berlin. With the 2025 European Society of Medical Oncology (ESMO) Congress starting on ...
Dana-Farber Cancer Institute researchers are leading four studies with important new findings in breast cancer, lung cancer, ...
When the organization now called the European Society for Medical Oncology (ESMO) opens its 50th anniversary Congress ...
A phase 2 trial evaluated the combination of neoadjuvant pembrolizumab and accelerated methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in patients with nonurothelial bladder cancers ...
To our knowledge, SunRISe-4 shows, for the first time, a benefit of the addition of the localised TAR-200 gemcitabine intravesical system to systemic checkpoint inhibition as neoadjuvant treatment in ...
A MAFS star has broken their silence after being cruelly targeted by a vile death hoax after their brave cancer battle. The ...
Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that it has entered into a partnership with Intelligent Scopes Corporation (ISC) to develop Artificial Intelligence (AI) software with ...
Researchers in China combined findings from MRI scans with clinical features to create a new predictive model for nonmuscle-invasive bladder cancer recurrence.
Talking With Docs on MSN
Understanding bladder cancer risk and treatment
Hamas Releases All 20 Surviving Hostages Under Gaza Ceasefire Deal As Trump Arrives In Israel Pastor shot by ICE with pepper ...
U of A Comprehensive Cancer Center Director Dr. Dan Theodorescu plans to study loss of Y chromosome biology and investigate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results